Mar 2024 Financial News

Agostini's Limited - Notice of Appointment of Senior Officer

Mar 13, 2024

Notice of Material Change
Appointment of CEO – Pharmaceutical Group

Agostini’s Limited wishes to announce that Mr. James Walker has been appointed to the new position of CEO – Pharmaceutical Group with effect from June 1st, 2024. The Group consists of Agostini’s pharmaceutical manufacturing and distribution businesses including Smith Robertson, Collins, Carlisle Laboratories and Health Brands.

James joined Agostini’s in 2022 as Chief Strategy Officer, and has been driving strategy development and execution, transformation and business development locally and across the region during this time. Prior to Agostini’s, James was an executive at Heritage Petroleum, a Senior Manager at McKinsey and Co. in London and Panama and held various commercial roles at BP in the US, UK and in Trinidad.

James holds a Masters in Economics from Yale University, and a Bachelors in Earth Science from Rice University. This notice is published pursuant to section 64 (1)(b) of the Securities Act 2012.
 

Source:
The Trinidad and Tobago Stock Exchange Limited
Wednesday 13th March, 2024